Krishnendu Chakraborty
Overview
Explore the profile of Krishnendu Chakraborty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
693
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cooper A, Sidaway A, Chandrashekar A, Latta E, Chakraborty K, Yu J, et al.
Cell Rep Med
. 2022 Dec;
3(12):100843.
PMID: 36480934
Despite rapid clinical translation of COVID-19 vaccines in response to the global pandemic, an opportunity remains for vaccine technology innovation to address current limitations and meet challenges of inevitable future...
2.
Matheson L, Petkau G, Saenz-Narciso B, DAngeli V, McHugh J, Newman R, et al.
Sci Rep
. 2022 Nov;
12(1):19657.
PMID: 36385275
The ZFP36 family of RNA-binding proteins acts post-transcriptionally to repress translation and promote RNA decay. Studies of genes and pathways regulated by the ZFP36 family in CD4 T cells have...
3.
Garg M, Johri S, Chakraborty K
FEBS J
. 2022 Jun;
290(18):4395-4418.
PMID: 35731715
In accordance with the endosymbiotic theory, mitochondrial components bear characteristic prokaryotic signatures, which act as immunomodulatory molecules when released into the extramitochondrial compartment. These endogenous immune triggers, called mitochondrial damage-associated...
4.
Petkau G, Mitchell T, Chakraborty K, Bell S, D Angeli V, Matheson L, et al.
Nat Commun
. 2022 Apr;
13(1):2274.
PMID: 35477960
CD8 T cell differentiation into effector cells is initiated early after antigen encounter by signals from the T cell antigen receptor and costimulatory molecules. The molecular mechanisms that establish the...
5.
Sivapalan R, Liu J, Chakraborty K, Arthofer E, Choudhry M, Barie P, et al.
Sci Rep
. 2021 Jul;
11(1):15295.
PMID: 34315945
The a priori T cell repertoire and immune response against SARS-CoV-2 viral antigens may explain the varying clinical course and prognosis of patients having a mild COVID-19 infection as opposed...
6.
Garg M, Johri S, Sagar S, Mundhada A, Agrawal A, Ray P, et al.
Cell Rep
. 2021 Feb;
34(6):108736.
PMID: 33567272
Bacterial pneumonia is a global healthcare burden, and unwarranted inflammation is suggested as an important cause of mortality. Optimum levels of the anti-inflammatory cytokine IL-10 are essential to reduce inflammation...
7.
Swan D, Aschenbrenner D, Lamb C, Chakraborty K, Clark J, Pandey S, et al.
Haematologica
. 2019 May;
104(10):e483-e486.
PMID: 31073077
No abstract available.
8.
Stark A, Chandra A, Chakraborty K, Alam R, Carbonaro V, Clark J, et al.
Nat Commun
. 2018 Aug;
9(1):3174.
PMID: 30093657
Streptococcus pneumoniae is a major cause of pneumonia and a leading cause of death world-wide. Antibody-mediated immune responses can confer protection against repeated exposure to S. pneumoniae, yet vaccines offer...
9.
Gauthier M, Chakraborty K, Oriss T, Raundhal M, Das S, Chen J, et al.
JCI Insight
. 2017 Jul;
2(13).
PMID: 28679952
We previously showed that Th1/type 1 inflammation marked by increased IFN-γ levels in the airways can be appreciated in 50% of patients with severe asthma, despite high dose corticosteroid (CS)...
10.
Oriss T, Raundhal M, Morse C, Huff R, Das S, Hannum R, et al.
JCI Insight
. 2017 May;
2(10).
PMID: 28515358
Severe asthma (SA) is a significant problem both clinically and economically, given its poor response to corticosteroids (CS). We recently reported a complex type 1-dominated (IFN-γ-dominated) immune response in more...